-
Mashup Score: 0
According to a follow-up survey by the National Comprehensive Cancer Network, 86% of cancer centers included are still experiencing oncology drug shortages.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“Where you live should not impact whether you live," said Robert W. Carlson, MD, NCCN Chief Executive Officer. The #NCCN is dedicated to ensuring every #cancer patient, no matter geographical residence, receives guideline-directed care. https://t.co/qoLqc8cJjU #healthcare https://t.co/IEI9SgssDS
-
-
Mashup Score: 0
Ropeginterferon alfa-2b-njft was added to the NCCN guidelines and granted category 2A status for the treatment of polycythemia vera.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In May 2023, Ropeginterferon alfa-2b-njft was added to the #NCCN guidelines and granted category 2A status for the treatment of polycythemia vera. #mpnsm https://t.co/znTvpPV4qC
-
-
Mashup Score: 1NCCN Guidelines Add Flotufolastat F 18 Injection for Prostate Cancer - 9 month(s) ago
Data from 2 studies, LIGHTHOUSE and SPOTLIGHT, have shown the benefit of flotufolastat F 18 injection as a radiohybrid PSMA-targeted pet imaging agent in prostate cancer. The agent has now been added to the NCCN guidelines.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #NCCN has updated its guidelines to include flotufolastat F 18 injection for patients with prostate cancer. #pcsm https://t.co/5ad7NcA14z
-
-
Mashup Score: 0NCCN Adds Pedmark to Guidelines for Pediatric Solid Tumors - 10 month(s) ago
The NCCN has recognized the importance of hearing loss in pediatric patients and therefore, added Pedmark to their adolescent and young adult oncology guidelines.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: The #NCCN has recognized the importance of hearing loss in pediatric patients and therefore, added Pedmark to their oncology guidelines. https://t.co/2lcs99roXs
-
-
Mashup Score: 0CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines - 1 year(s) ago
Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines. #oncology #nursing #NCCN #geneticconditions #AACR23 @MayoClinic link: https://t.co/2GwzeGx42O https://t.co/gxK1Jlnouv
-
-
Mashup Score: 0CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines - 1 year(s) ago
Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines. #oncology #nursing #NCCN #geneticconditions #AACR23 @MayoClinic https://t.co/IvJSCrD5H3
-
-
Mashup Score: 0CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines - 1 year(s) ago
Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines #oncology #nursing #NCCN #geneticconditions #AACR23 @MayoClinic https://t.co/wVdBMoIFV7
-
-
Mashup Score: 0Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer - 1 year(s) ago
Background: We sought to investigate the impact of an NCCN-compliant multidisciplinary conference on treatment decisions of patients with localized prostate cancer. Methods: A retrospective review of our quality assurance localized prostate cancer database was performed. All patients with localized prostate cancer who sought a second opinion at Roswell Park Comprehensive Cancer Center between…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Impact of an #NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized #ProstateCancer: https://t.co/onVBb6ZHqB @A_Aly_Hussein @umariqbalmed @jamesmohlermd @khurshidguru et al of @RoswellPark #PCSM #CCDR https://t.co/cW6IfwodLh
-
-
Mashup Score: 0
In an interview, Edwin Choy, MD, discussed the treatment landscape of GIST and recent changes to NCCN guidelines.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In an interview with Targeted Oncology, Edwin Choy, MD, discussed the treatment landscape of #GIST and recent changes to #NCCN guidelines. @MGHMedicine @MGHCancerCenter https://t.co/duLqM0yCHh https://t.co/Tc2tkIcbzP
-
Despite initial efforts to mitigate the ongoing shortage of oncology drugs, a follow-up survey conducted by the #NCCN showed that carboplatin and cisplatin remain in short supply. https://t.co/39MHA7PBGk https://t.co/KFEsCVkbYn